Biodel (BIOD) Closes 37.5M Common Stock Offering
- S&P 500, Dow set to rise as economic growth heats up
- Didi (DIDI) Gains on WSJ Report It Considers Going Private, Company Denies
- Facebook (FB) Tops Profit and Revenue Estimates, But Shares Lower on Warning of Significant Growth Slowdown, Analyst Still Raises PT to a New 'Street High'
- Robinhood (HOOD) Priced IPO at Lower End of Range as Some Investors Stayed on Sidelines Over Frothy Valuation
- Hang Seng Index Rebounds as China Moves to Reassure Investors It Will Allow US IPOs
On April 20, 2015, Biodel (Nasdaq: BIOD) closed its previously-announced underwritten public offering of 37,500,000 shares of common stock, par value $0.01 per share (which amount includes the full exercise of the underwriter’s option to purchase 4,891,304 shares to cover overallotments), at a price to the public of $.92 per share, resulting in net proceeds of approximately $32,068,750, after deducting underwriting discounts and commissions and estimated offering expenses. The Company intends to use the proceeds from the offering for operating costs, capital expenditures and for general corporate purposes, including working capital. William Blair & Company, L.L.C. and Ladenburg Thalmann & Co. Inc. acted as the joint book-running managers for the offering. Roth Capital Partners, LLC acted as co-manager.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Duolingo (DUOL) IPO Opens 39% Higher
- PowerSchool Announces Pricing of Initial Public Offering
- MeridianLink (MLNK) IPO Opens Higher, Trends Lower
Create E-mail Alert Related CategoriesEquity Offerings
Related EntitiesWilliam Blair, Roth Capital, Ladenburg Thalmann Financial Services
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!